Clinical Study of mRNA Vaccine Combined With PD-1 Inhibitor as Adjuvant Therapy for Postoperative Pancreatic Cancer
Clinical trial NCT06496373 · RECRUITING
Trial details
- NCT number
- NCT06496373
- Sponsor
- Ruijin Hospital
- Status
- RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-16
- Primary completion
- 2026-06-30
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.